OBJECTIVES: Our objective is to explore how vasculitis affects patients' friendships and social participation. METHODS: Vasculitis patients (n=221) completed an online questionnaire that asked if, and how, relationships with friends have changed since receiving a vasculitis diagnosis. Participants' written responses were imported into Atlas.ti, and two independent researchers used both structured and unstructured coding to identify themes. After reaching 100% consensus on the themes present in each participant's responses, the coders determined how themes were interrelated across participants. RESULTS: Over half of patients (52%) expressed that vasculitis negatively impacted their friendships and 25% noted a negative impact on their social participation. At times, this negative impact was related to structural changes in patients' social networks due to loss of friendships. Reduced social participation was also associated with friends' inability to understand vasculitis and its effects, vasculitis-related fatigue, and lifestyle changes such as not being able to drink alcohol and avoiding infection-prone events. Additionally, patients withdrew from social engagements due to fatigue or because of physical symptoms and side effects. CONCLUSIONS: The unique circumstances associated with a rare chronic illness like vasculitis can create significant barriers to friendships, including loss of these relationships. Interventions designed to help patients cope with the social impact of vasculitis are implicated, especially if they increase patients' ability to engage in dialogue about their illness with their friends.
OBJECTIVES: Our objective is to explore how vasculitis affects patients' friendships and social participation. METHODS:Vasculitispatients (n=221) completed an online questionnaire that asked if, and how, relationships with friends have changed since receiving a vasculitis diagnosis. Participants' written responses were imported into Atlas.ti, and two independent researchers used both structured and unstructured coding to identify themes. After reaching 100% consensus on the themes present in each participant's responses, the coders determined how themes were interrelated across participants. RESULTS: Over half of patients (52%) expressed that vasculitis negatively impacted their friendships and 25% noted a negative impact on their social participation. At times, this negative impact was related to structural changes in patients' social networks due to loss of friendships. Reduced social participation was also associated with friends' inability to understand vasculitis and its effects, vasculitis-related fatigue, and lifestyle changes such as not being able to drink alcohol and avoiding infection-prone events. Additionally, patients withdrew from social engagements due to fatigue or because of physical symptoms and side effects. CONCLUSIONS: The unique circumstances associated with a rare chronic illness like vasculitis can create significant barriers to friendships, including loss of these relationships. Interventions designed to help patients cope with the social impact of vasculitis are implicated, especially if they increase patients' ability to engage in dialogue about their illness with their friends.
Authors: Delesha M Carpenter; Jessica A Kadis; Robert F Devellis; Susan L Hogan; Joanne M Jordan Journal: J Rheumatol Date: 2011-02-01 Impact factor: 4.666
Authors: Neil Basu; Gareth T Jones; Nick Fluck; Alan G MacDonald; Dong Pang; Paula Dospinescu; David M Reid; Gary J Macfarlane Journal: Rheumatology (Oxford) Date: 2010-04-17 Impact factor: 7.580
Authors: Rula A Hajj-Ali; William S Wilke; Leonard H Calabrese; Gary S Hoffman; Xiaobo Liu; James Bena; Tiffany Clark; Carol A Langford Journal: Arthritis Care Res (Hoboken) Date: 2011-06 Impact factor: 4.794
Authors: Gunnar Tomasson; John T Farrar; David Cuthbertson; Carol A McAlear; Susan Ashdown; Peter F Cronholm; Jill Dawson; Don Gebhart; Georgia Lanier; Raashid A Luqmani; Nataliya Milman; Jacqueline Peck; Joanna C Robson; Judy A Shea; Simon Carette; Nader Khalidi; Curry L Koening; Carol A Langford; Paul A Monach; Larry Moreland; Christian Pagnoux; Ulrich Specks; Antoine G Sreih; Steven R Ytterberg; Peter A Merkel Journal: J Rheumatol Date: 2019-03-01 Impact factor: 4.666
Authors: Nicola Luigi Bragazzi; Abdulla Watad; Francesco Brigo; Mohammad Adawi; Howard Amital; Yehuda Shoenfeld Journal: Clin Rheumatol Date: 2016-12-20 Impact factor: 3.650
Authors: Dayna S Alexander; Susan L Hogan; Joanne M Jordan; Robert F DeVellis; Delesha M Carpenter Journal: Patient Prefer Adherence Date: 2017-01-12 Impact factor: 2.711
Authors: Lorraine Harper; Matthew David Morgan; Dimitrios Chanouzas; Hollie K Caulfield; Linda Coughlan; Caroline Dean; Kate Fletcher; Fiona Cramp; Sheila Greenfield; Catherine A Hewitt; Natalie J Ives; Sue Jowett; Amanda Daley Journal: BMJ Open Date: 2018-10-30 Impact factor: 2.692